What is he best known for?
The fields of study he is best known for:
Zhu Chen mainly investigates Acute promyelocytic leukemia, Genetics, Arsenic trioxide, Leukemia and Cancer research.
His work carried out in the field of Acute promyelocytic leukemia brings together such families of science as Internal medicine and Tretinoin, Cellular differentiation.
His research investigates the link between Genetics and topics such as Evolutionary biology that cross with problems in Haplotype and Y chromosome.
He combines subjects such as Combination therapy, Pathogenesis and Acute promyelocytic leukaemia with his study of Arsenic trioxide.
His Leukemia research is multidisciplinary, incorporating perspectives in Myeloid and Myeloid leukemia.
His Cancer research research incorporates elements of Mutation, Exome sequencing, Exome and Chemotherapy.
His most cited work include:
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients. (1013 citations)
- Acute promyelocytic leukemia: from highly fatal to highly curable. (907 citations)
- A Human Genome Diversity Cell Line Panel (849 citations)
What are the main themes of his work throughout his whole career to date?
Zhu Chen mainly focuses on Cancer research, Acute promyelocytic leukemia, Leukemia, Molecular biology and Cell biology.
His primary area of study in Cancer research is in the field of Myeloid leukemia.
His biological study spans a wide range of topics, including Arsenic trioxide and Tretinoin, Cellular differentiation.
His Arsenic trioxide research incorporates themes from Gastroenterology and Internal medicine, Chemotherapy.
In his research, CD34 is intimately related to Myeloid, which falls under the overarching field of Leukemia.
His research integrates issues of Gene rearrangement, Chromosomal translocation, Fusion gene, Gene and Regulation of gene expression in his study of Molecular biology.
He most often published in these fields:
- Cancer research (36.39%)
- Acute promyelocytic leukemia (23.99%)
- Leukemia (24.80%)
What were the highlights of his more recent work (between 2015-2021)?
- Cell biology (18.87%)
- Cancer research (36.39%)
- Leukemia (24.80%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cell biology, Cancer research, Leukemia, Haematopoiesis and Myeloid leukemia.
His research in Cancer research intersects with topics in Mutation, Fusion gene, Acute promyelocytic leukemia, Promyelocytic leukemia protein and Genome.
The Acute promyelocytic leukemia study combines topics in areas such as Internal medicine, Toxicity and Targeted therapy.
His studies in Leukemia integrate themes in fields like Myeloid and Immunophenotyping.
His Myeloid leukemia research is multidisciplinary, incorporating elements of Molecular biology, Downregulation and upregulation and DOT1L.
He interconnects Arsenic trioxide and Retinoic acid in the investigation of issues within Pharmacology.
Between 2015 and 2021, his most popular works were:
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients. (1013 citations)
- Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia. (115 citations)
- The P4 Health Spectrum – A Predictive, Preventive, Personalized and Participatory Continuum for Promoting Healthspan (96 citations)
In his most recent research, the most cited papers focused on:
Zhu Chen mostly deals with Cancer research, Leukemia, Internal medicine, Myeloid leukemia and Cell biology.
His Cancer research study integrates concerns from other disciplines, such as Kinase activity, Targeted therapy, Gefitinib, Lung cancer and Promyelocytic leukemia protein.
The concepts of his Leukemia study are interwoven with issues in Myeloid, Receptor, Immunophenotyping, CD19 and Immunotherapy.
His work deals with themes such as Gastroenterology and Antibody, which intersect with Internal medicine.
His Myeloid leukemia research includes elements of Molecular biology and Downregulation and upregulation.
His Gene expression research is multidisciplinary, relying on both Acute promyelocytic leukemia and Retinoic acid.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
